Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adams Laboratories, Inc.
Valentino named president, CEO of respiratory drug development company
September 10th, 2003
Adams Laboratories, Inc., announced the appointment of Michael J. Valentino to the position of president, CEO, and director. Valentino, 49, succeeds Mark J. Gainor, a member of the board of directors who has served as Adams Laboratories' interim CEO since May 1. Gainor will remain with the company as a director. "Mike's 25 years of relevant industry experience coupled with his management expertise will drive our organization forward to become the leading specialty provider of pharmaceuticals for respiratory care," said Gainor. "Mike is a strategic thinker and great leader, and he has the respect of our entire Board. Under his guidance, we are...
Source: Biotech Week (2003-09-10)
|
